KKR & Co. Inc. (NYSE:KKR) Shares Acquired by Signaturefd LLC

Signaturefd LLC lifted its holdings in shares of KKR & Co. Inc. (NYSE:KKRFree Report) by 2.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 8,298 shares of the asset manager’s stock after buying an additional 194 shares during the period. Signaturefd LLC’s holdings in KKR & Co. Inc. were worth $1,227,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. AdvisorNet Financial Inc boosted its position in shares of KKR & Co. Inc. by 417.8% during the fourth quarter. AdvisorNet Financial Inc now owns 2,180 shares of the asset manager’s stock worth $322,000 after buying an additional 1,759 shares during the period. BNP PARIBAS ASSET MANAGEMENT Holding S.A. boosted its position in shares of KKR & Co. Inc. by 8.9% during the third quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 57,886 shares of the asset manager’s stock worth $7,559,000 after buying an additional 4,719 shares during the period. Whalen Wealth Management Inc. acquired a new position in shares of KKR & Co. Inc. during the fourth quarter worth approximately $667,000. Caldwell Investment Management Ltd. boosted its position in shares of KKR & Co. Inc. by 2.9% during the fourth quarter. Caldwell Investment Management Ltd. now owns 212,400 shares of the asset manager’s stock worth $31,477,000 after buying an additional 5,900 shares during the period. Finally, Jupiter Asset Management Ltd. lifted its position in KKR & Co. Inc. by 50.9% in the fourth quarter. Jupiter Asset Management Ltd. now owns 114,184 shares of the asset manager’s stock worth $16,889,000 after purchasing an additional 38,524 shares during the period. 76.26% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at KKR & Co. Inc.

In other KKR & Co. Inc. news, major shareholder Genetic Disorder L.P. Kkr sold 6,000,000 shares of the business’s stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of $32.96, for a total transaction of $197,760,000.00. Following the sale, the insider now directly owns 19,260,971 shares of the company’s stock, valued at $634,841,604.16. The trade was a 23.75 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 39.34% of the company’s stock.

KKR & Co. Inc. Price Performance

Shares of NYSE:KKR opened at $113.99 on Wednesday. The company’s fifty day moving average is $140.81 and its two-hundred day moving average is $141.71. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.82. KKR & Co. Inc. has a 12-month low of $91.92 and a 12-month high of $170.40. The company has a market cap of $101.25 billion, a P/E ratio of 34.23, a price-to-earnings-growth ratio of 1.00 and a beta of 1.72.

KKR & Co. Inc. Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Friday, February 14th were paid a dividend of $0.175 per share. This represents a $0.70 annualized dividend and a yield of 0.61%. The ex-dividend date of this dividend was Friday, February 14th. KKR & Co. Inc.’s dividend payout ratio (DPR) is currently 21.02%.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. Barclays cut their target price on KKR & Co. Inc. from $185.00 to $181.00 and set an “overweight” rating for the company in a research report on Wednesday, February 5th. The Goldman Sachs Group upped their target price on KKR & Co. Inc. from $160.00 to $177.00 and gave the stock a “buy” rating in a research report on Tuesday, November 19th. Wells Fargo & Company cut their target price on KKR & Co. Inc. from $151.00 to $150.00 and set an “equal weight” rating for the company in a research report on Wednesday, February 5th. Morgan Stanley cut their target price on KKR & Co. Inc. from $157.00 to $156.00 and set an “equal weight” rating for the company in a research report on Thursday, February 6th. Finally, Oppenheimer upped their target price on KKR & Co. Inc. from $153.00 to $175.00 and gave the stock an “outperform” rating in a research report on Thursday, December 12th. One analyst has rated the stock with a sell rating, four have given a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $161.43.

Read Our Latest Analysis on KKR & Co. Inc.

KKR & Co. Inc. Company Profile

(Free Report)

KKR & Co, Inc operates as an investment firm. It offers alternative asset management as well as capital markets and insurance solutions. The firm’s business segments include Asset Management and Insurance Business. The Asset Management segment engages in providing private equity, real assets, credit and liquid strategies, capital markets, and principal activities.

Read More

Want to see what other hedge funds are holding KKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for KKR & Co. Inc. (NYSE:KKRFree Report).

Institutional Ownership by Quarter for KKR & Co. Inc. (NYSE:KKR)

Receive News & Ratings for KKR & Co. Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KKR & Co. Inc. and related companies with MarketBeat.com's FREE daily email newsletter.